EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1) (C-Term) Peptide
-
- Target See all EPM2AIP1 products
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- EKAFSYLTRN QHTLSQPLTD EHLQALFRVA TTEMEPGWDD LVRERNESNP
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- EPM2AIP1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
- Synonyms
- EPM2AIP1 Peptide, DKFZp459D2251 Peptide, A930003G21Rik Peptide, mKIAA0766 Peptide, EPM2A interacting protein 1 Peptide, EPM2A (laforin) interacting protein 1 Peptide, EPM2AIP1 Peptide, Epm2aip1 Peptide
- Background
-
The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless.
Protein Size: 607 - Gene ID
- 9852
- NCBI Accession
- NM_014805, NP_055620
- UniProt
- Q7L775
-